TV-44749 is a subcutaneous long-acting injectable form of olanzapine that is effective in schizophrenia while avoiding risks seen with the intramuscular formulation.
Mark Olivas, PharmD
Advertisement
Articles by Mark Olivas, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis Cases Reach 5100: Investigators Zero In On Lettuce, Possible Taco Bell Link
2
Gedatolisib Combination Approved for PIK3CA Wild-Type HR+, HER2– Breast Cancer
3
Subcutaneous Olanzapine in Schizophrenia: Expanding the Utility of a Proven Therapy
4
Remote Patient Monitoring in Myeloma: How Technology Is Transforming Bispecific Antibody Management
5